Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms, Germ Cell and Embryonal 1Bone Cysts 1

Interventions

rolapitant 1bintrafusp alfa protein, human 1Tetrahydrouridine 1Steroids 1Palonosetron 1Olanzapine 1Nivolumab 1Dexamethasone 1Decitabine 1Celecoxib 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Neoplasms, Germ Cell and Embryonal × Steroids × Clear all
NCT03960151 2019-05-22

Rolapitant Plus Olanzapine in Multiday Cisplatin Chemotherapy

Hoosier Cancer Research Network

Phase 2 Withdrawn

Neoplasms, Germ Cell and Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡